Ganot Ilan 4

4 · Solid Biosciences Inc. · Filed Feb 18, 2026

AI-generated summary of this filing

Updated Feb 19, 2026

Solid Biosciences (SLDB) Director Ilan Ganot Sells Shares After RSU Conversion

What Happened

Ilan Ganot, a director of Solid Biosciences (SLDB), had 4,861 restricted stock units (RSUs) convert into 4,861 common shares on Feb 13, 2026 (conversion/exercise, code M). Following the conversion, Ganot sold 2,658 of those shares in an open-market sell-to-cover transaction on Feb 18, 2026 for total proceeds of $15,478 (weighted average price $5.82). The conversion itself generated no cash proceeds (reported at $0).

Key Details

Transaction dates and prices:
- Feb 13, 2026: 4,861 RSUs converted to 4,861 common shares (one-for-one conversion; code M).
- Feb 18, 2026: 2,658 shares sold (code S) at a weighted average price of $5.82, total proceeds $15,478. Sales prices ranged from $5.23 to $6.14.
Shares owned after transaction: total reported holdings equal 118,691 shares (95,255 held individually, 4,042 held jointly with Annie Ganot, and 19,394 held in the Ilan Ganot 2017 Irrevocable Trust).
Notable footnotes:
- F1/F6: The shares resulted from RSUs that convert one-for-one; 19,444 RSUs were originally granted on Feb 13, 2024, vesting in four equal annual installments (4,861 per installment).
- F3: The Feb 18 sale was a sell-to-cover to satisfy withholding taxes under a durable automatic sales instruction (not a discretionary trade).
- F4: Reported sale price is a weighted average; detailed per-trade prices are available on request.
Filing timeliness: Form 4 was filed Feb 18, 2026; no late-filing flag is indicated.

Context

This was not a cash-buy; it was an RSU vesting event (conversion of equity award) followed by a sell-to-cover to satisfy taxes. Such sales to cover tax withholding are routine and do not necessarily indicate the insider’s view on the company’s prospects.
Transaction codes: M = exercise or conversion of a derivative (here, RSU vesting/conversion); S = sale; the disposal of converted shares for $0 reflects the non-cash conversion of RSUs.

Form 4

Period: 2026-02-13

Director

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-02-13+4,861→ 30,132 total(indirect: By Spouse)
Sale
Common Stock
[F3][F4]
2026-02-18$5.82/sh−2,658$15,478→ 27,474 total(indirect: By Spouse)
Exercise/Conversion
Restricted Stock Units
[F1][F6]
2026-02-13−4,861→ 9,722 total(indirect: By Spouse)
→ Common Stock (4,861 underlying)

Holdings

Footnotes (6)

[F1]Restricted stock units convert into common stock on a one-for-one basis.
[F2]Represents 95,255 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.
[F3]This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot.
[F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.23 to $6.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form.
[F5]Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.
[F6]On February 13, 2024 (the "Grant Date") Ms. Ganot was granted 19,444 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

Signature

/s/ David Tyronne Howton as attorney-in-fact for Ilan Ganot|2026-02-18

1 file